You are here: Home » Government Press Release » News
Business Standard

CCRAS has Completed Clinical Research in 94 Projects of Ayurveda: Shri Shripad Naik

Delhi 

  • ALSO READ

CCRAS has Completed Clinical Research in 94 Projects of Ayurveda: Shri Shripad Naik

Central Council for Research in Ayurvedic Sciences (CCRAS) has undertaken clinical study of 17 formulations for reproductive and child health care and 8 formulations under drug development are in progress. CCRAS has completed clinical research in 94 projects. Clinical research in 14 cases is on-going and in 28 cases Clinical Research is to be initiated.

Ayurvedic, Siddha or Unani drugs are sold under license given by the State Licensing Authorities. Rule 158 B of the Drugs and Cosmetics Rules, 1945 prescribes regulatory requirements including submission of proof of safety and effectiveness for licensing of Ayurvedic, Siddha or Unani drugs. Enforcement of these provisions is under purview of the State Licensing Authorities appointed by the State Governments. Directive is issued to all state Licensing Authorities, Research Councils, National Institutes, Health Universities and Ayurvedic, Siddha or Unani Drugs manufacturers Associations to ensure registration of the clinical trials of in the Clinical Trials Registry of India (CTRI).

This information was given by the Minister of State (Independent Charge) for AYUSH, Shri Shripad Yesso Naik in written reply to a question in Rajya Sabha today.

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

RECOMMENDED FOR YOU

CCRAS has Completed Clinical Research in 94 Projects of Ayurveda: Shri Shripad Naik

CCRAS has Completed Clinical Research in 94 Projects of Ayurveda: Shri Shripad Naik
CCRAS has Completed Clinical Research in 94 Projects of Ayurveda: Shri Shripad Naik

Central Council for Research in Ayurvedic Sciences (CCRAS) has undertaken clinical study of 17 formulations for reproductive and child health care and 8 formulations under drug development are in progress. CCRAS has completed clinical research in 94 projects. Clinical research in 14 cases is on-going and in 28 cases Clinical Research is to be initiated.

Ayurvedic, Siddha or Unani drugs are sold under license given by the State Licensing Authorities. Rule 158 B of the Drugs and Cosmetics Rules, 1945 prescribes regulatory requirements including submission of proof of safety and effectiveness for licensing of Ayurvedic, Siddha or Unani drugs. Enforcement of these provisions is under purview of the State Licensing Authorities appointed by the State Governments. Directive is issued to all state Licensing Authorities, Research Councils, National Institutes, Health Universities and Ayurvedic, Siddha or Unani Drugs manufacturers Associations to ensure registration of the clinical trials of in the Clinical Trials Registry of India (CTRI).

This information was given by the Minister of State (Independent Charge) for AYUSH, Shri Shripad Yesso Naik in written reply to a question in Rajya Sabha today.

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

image
Business Standard
177 22

CCRAS has Completed Clinical Research in 94 Projects of Ayurveda: Shri Shripad Naik

CCRAS has Completed Clinical Research in 94 Projects of Ayurveda: Shri Shripad Naik

Central Council for Research in Ayurvedic Sciences (CCRAS) has undertaken clinical study of 17 formulations for reproductive and child health care and 8 formulations under drug development are in progress. CCRAS has completed clinical research in 94 projects. Clinical research in 14 cases is on-going and in 28 cases Clinical Research is to be initiated.

Ayurvedic, Siddha or Unani drugs are sold under license given by the State Licensing Authorities. Rule 158 B of the Drugs and Cosmetics Rules, 1945 prescribes regulatory requirements including submission of proof of safety and effectiveness for licensing of Ayurvedic, Siddha or Unani drugs. Enforcement of these provisions is under purview of the State Licensing Authorities appointed by the State Governments. Directive is issued to all state Licensing Authorities, Research Councils, National Institutes, Health Universities and Ayurvedic, Siddha or Unani Drugs manufacturers Associations to ensure registration of the clinical trials of in the Clinical Trials Registry of India (CTRI).

This information was given by the Minister of State (Independent Charge) for AYUSH, Shri Shripad Yesso Naik in written reply to a question in Rajya Sabha today.

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

image
Business Standard
177 22

Upgrade To Premium Services

Welcome User

Business Standard is happy to inform you of the launch of "Business Standard Premium Services"

As a premium subscriber you get an across device unfettered access to a range of services which include:

  • Access Exclusive content - articles, features & opinion pieces
  • Weekly Industry/Genre specific newsletters - Choose multiple industries/genres
  • Access to 17 plus years of content archives
  • Set Stock price alerts for your portfolio and watch list and get them delivered to your e-mail box
  • End of day news alerts on 5 companies (via email)
  • NEW: Get seamless access to WSJ.com at a great price. No additional sign-up required.
 

Premium Services

In Partnership with

 

Dear Guest,

 

Welcome to the premium services of Business Standard brought to you courtesy FIS.
Kindly visit the Manage my subscription page to discover the benefits of this programme.

Enjoy Reading!
Team Business Standard